Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISV-403 (Besivance) in bacterial conjunctivitis
NCT00622908Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Dec 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of besifloxacin in bacterial conjunctivitis (BC), sponsored by Bausch + Lomb. Started Dec 2004; status: completed.
02
Drugs
besifloxacin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00622908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622908.